biomedical research – Genentech
Posted: August 2, 2015 at 8:47 pm
We're passionate about helping people combat the world's hardest-to-treat diseases. So we constantly challenge ourselves to expand our scientific expertise, increase our technological understanding, and pursue our passion. To us, science is personal. Read Our Vision
Dietmar Berger discusses the role of the HER2 receptor in metastatic breast cancer.
Array biopharma and Genentech's strategic alliance was voted Breakthrough Alliance of 2012. Partner with us.
We support investigators in academia by supplying key reagents. Request proteins, antibodies, and cDNAs.
We're honored to earn a place on FORTUNE's "100 Best Companies to Work For" list for the 17th consecutive year.
Genentech Cancer Genome Project scientists have identified ERBB3 somatic mutations in human cancers. Learn more and read our publication in Cancer Cell.
Genentech is actively seeking applications for Independent Research Projects.
Scientists are at the core of our business. Learn about what inspires them every day.
Scientists know that the work theyre doing has a profound impact on peoples lives. In this video they talk about increasing the rate of success by turning failures into learning opportunities.
Chris Bowden explains the RAS-RAF pathway, an important and evolving area of cancer research.
View original post here:
biomedical research - Genentech